Irish-led project has potential to revolutionise cystic fibrosis treatment

The CF Matters (Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified) project will receive €6 million in funding from the European Union’s Seventh Framework Programme. The study aims to pave the way for more effective therapeutic regimes and ultimately contribute to the development of personalised CF treatment tailored to individual patients.

See More